Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Lachmann

Showing results (241-250 of 287) with videos related to

Pageof 29
Sort By:
Clinical Science and Molecular Medicine|February 1, 1974
Proceedings: Metabolism of C3 and glycine-rich beta glycoprotein (GBG) in hypocomplementaemiaD K Peters, J A Charlesworth, D G Williams, et al.
The Journal of Biological Chemistry|March 10, 1985
A synthetic nonapeptide corresponding to the NH2-terminal sequence of C3d-K causes leukocytosis in rabbitsP D Hoeprich, C A Dahinden, P J Lachmann, et al.
Complement (Basel, Switzerland)|January 1, 1988
Structure of C3f, a small peptide specifically released during inactivation of the third component of complementR A Harrison, T C Farries, F D Northrop, et al.
Current Pharmaceutical Design|September 24, 2004
Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeuticsP S Hiemstra, B A Fernie-King, J McMichael, et al.
Biochemistry|February 6, 1990
Structural homologies of component C5 of human complement with components C3 and C4 by neutron scatteringS J Perkins, K F Smith, A S Nealis, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1981
Effects of clonidine on gastric acid secretion in the ratH C Cheng, E M Gleason, B A Nathan, et al.
Nature|October 29, 1971
Lesions due to complement in lipid membranesT R Hesketh, R R Dourmashkin, S N Payne, et al.
The Journal of Experimental Medicine|July 1, 1990
Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysisS Meri, B P Morgan, M Wing, et al.
Journal of Virology|December 1, 1994
Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cellY Takeuchi, F L Cosset, P J Lachmann, et al.
European Journal of Immunology|March 1, 1984
Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1)N Hogg, G D Ross, D B Jones, et al.
Pageof 29

Showing results (241-250 of 287) with videos related to

Sort By:
Pageof 29
Clinical Science and Molecular Medicine|February 1, 1974
Proceedings: Metabolism of C3 and glycine-rich beta glycoprotein (GBG) in hypocomplementaemiaD K Peters, J A Charlesworth, D G Williams, et al.
The Journal of Biological Chemistry|March 10, 1985
A synthetic nonapeptide corresponding to the NH2-terminal sequence of C3d-K causes leukocytosis in rabbitsP D Hoeprich, C A Dahinden, P J Lachmann, et al.
Complement (Basel, Switzerland)|January 1, 1988
Structure of C3f, a small peptide specifically released during inactivation of the third component of complementR A Harrison, T C Farries, F D Northrop, et al.
Current Pharmaceutical Design|September 24, 2004
Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeuticsP S Hiemstra, B A Fernie-King, J McMichael, et al.
Biochemistry|February 6, 1990
Structural homologies of component C5 of human complement with components C3 and C4 by neutron scatteringS J Perkins, K F Smith, A S Nealis, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1981
Effects of clonidine on gastric acid secretion in the ratH C Cheng, E M Gleason, B A Nathan, et al.
Nature|October 29, 1971
Lesions due to complement in lipid membranesT R Hesketh, R R Dourmashkin, S N Payne, et al.
The Journal of Experimental Medicine|July 1, 1990
Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysisS Meri, B P Morgan, M Wing, et al.
Journal of Virology|December 1, 1994
Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cellY Takeuchi, F L Cosset, P J Lachmann, et al.
European Journal of Immunology|March 1, 1984
Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1)N Hogg, G D Ross, D B Jones, et al.
Pageof 29